NCT05289648 2024-12-19
NIREC
Sir Mortimer B. Davis - Jewish General Hospital
Phase EARLY_PHASE1 Withdrawn
Clinical Trials
8 trialsNCT00250770 2023-07-05
Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
University of New Mexico
Withdrawn
NCT04368130 2022-10-14
SIGNAL
Dana-Farber Cancer Institute
Phase NA Withdrawn
NCT03583736 2020-06-30
Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT00588263 2018-02-19
Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Memorial Sloan Kettering Cancer Center
Withdrawn
NCT01176500 2017-07-02
A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1/2 Withdrawn
NCT02095847 2015-04-08
High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT01290406 2012-06-21
BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
Novartis
Phase 2 Withdrawn